Category: Pharma Industry

Two Drugmakers Offer Refunds for 340B Overcharges

November 28, 2023 Tom Mirga, Editor at Large Views

Two drugmakers, Mallinckrodt's subsidiary SpecGx and Novo Nordisk, owe refunds to 340B providers for certain overcharges.

Two drugmakers will offer refunds to 340B providers for overcharges in recent years. Drug manufacturer Mallinckrodt’s SpecGx generic pharmaceutical subsidiary [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Michigan Bill Introduced to Protect 340B Contract Pharmacy Arrangements

November 17, 2023 William Newton, Associate Editor/Senior Writer Views

Michigan state Rep. Alabas Farhat (D) introduced a bipartisan bill designed to protect 340B contract pharmacy arrangements in the state.

Michigan state lawmakers this week introduced a bill designed to protect 340B contract pharmacy arrangements from drug manufacturer restrictions. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Reforms Urged by Centrist Democrat Group with Drugmaker Ties

November 17, 2023 Rich Daly, Editor in Chief Views

Darbin Wofford, a health policy advisor at Third Way, said his organization is urging Congressional Democrats to adopt 340B program reforms.

A center-left group that has received pharmaceutical industry funding is urging a series of 340B reforms that it hopes to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Jazz Pharmaceuticals Posts Refund Notice on HRSA Website

November 17, 2023 Rich Daly, Editor in Chief Views

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on HRSA's website.

Jazz Pharmaceuticals owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Lilly to Exempt Arkansas Providers from New Tighter 340B Contract Pharmacy Restrictions

November 15, 2023 William Newton, Associate Editor/Senior Writer Views

Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.

Pharmaceutical giant Eli Lilly will exempt Arkansas covered entities from its latest 340B contract pharmacy restrictions in response to an [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Court Sets November 2024 Trial for Novo Nordisk’s Arkansas 340B Lawsuit

November 15, 2023 William Newton, Associate Editor/Senior Writer Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

The trial for drugmaker Novo Nordisk’s legal challenge to Arkansas’ 340B contract pharmacy law will wait a year to commence. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Novo Nordisk’s 340B Arkansas Lawsuit Reassigned to Judge Who Previously Ruled Against Drugmakers

November 9, 2023 William Newton, Associate Editor/Senior Writer Views

Novo Nordisk and the Arkansas Insurance Department are at odds over whether a federal district court should intervene in the enforcement of Arkansas' 340B contract pharmacy law.

A federal district court transferred drugmaker Novo Nordisk’s lawsuit challenging Arkansas’ 340B contract pharmacy law to a judge who previously [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Louisiana Provider Group to Intervene in 340B Contract Pharmacy Lawsuit

November 9, 2023 William Newton, Associate Editor/Senior Writer Views

A federal district judge allowed the Louisiana Primary Care Association's to intervene in a second drug industry lawsuit challenging Louisiana's 340B contract pharmacy law.

A federal judge allowed a Louisiana provider group to join the state attorney general in defending Louisiana’s 340B contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Hospitals Charge Higher Commercial Insurance Prices, Says PhRMA Funded Report

November 9, 2023 Rich Daly, Editor in Chief Views

Neil Masia, Ph.D., authored a Health Capital Group report that found 340B hospitals charge higher commercial insurance prices than non-340B hospitals.

The average hospital in the 340B program charges commercial insurers more than non-340B hospitals, according to a new report, which [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

GlaxoSmithKline Posts Refund Notice on HRSA Website

November 9, 2023 Rich Daly, Editor in Chief Views

GlaxoSmithKline and Pfizer announced updates to their 340B contract pharmacy policies to comply with new state laws that will take effect in July.

GlaxoSmithKline owes refunds to 340B providers, according to a notice posted on the Health Resources and Services Administration’s Office of [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live